Jennifer Michaelson
Chief Tech/Sci/R&D Officer presso CULLINAN THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Jennifer Michaelson is currently the Chief Scientific Officer at Cullinan Oncology, Inc. She previously worked as the Director-Tumor Immunology at Jounce Therapeutics, Inc. and as the Chief Development Officer-Biologics at Cullinan Oncology LLC from 2020 to 2022.
Additionally, she served as the Head-Biologics at Celsius Therapeutics, Inc. in 2017.
Dr. Michaelson completed her undergraduate degree at Princeton University and obtained a doctorate from Albert Einstein College of Medicine, Inc.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
22/02/2024 | 137 582 ( 0.32% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Jennifer Michaelson
Società | Posizione | Inizio |
---|---|---|
CULLINAN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2023 |
Precedenti posizioni note di Jennifer Michaelson
Società | Posizione | Fine |
---|---|---|
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/12/2017 |
JOUNCE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2017 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Jennifer Michaelson
Princeton University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CULLINAN THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Jennifer Michaelson